AzTrials
AzTrials

Stroke, CardiovascularNCT03466372

Innovative Gait Biofeedback Strategies for Stroke Rehabilitation

A study testing biofeedback in people with Stroke, Cardiovascular and Gait, Hemiplegic, run by Emory University at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The long-term study goal is to develop a more engaging, motivating gait biofeedback methodologies specifically designed for post-stroke gait training. The current project aims to address fundamental questions regarding the optimal methodology to deliver AGRF biofeedback during gait, and the feasibility and preliminary… Read more about this study

Who is it for?
Ages 18 to 90 yearsHealthy volunteers can take part
Conditions the study is for
Stroke, Cardiovascular, Gait, Hemiplegic
What is being tested?
biofeedback
Could I receive a placebo?
No, everyone receives an active treatment
How many people
20 participants
Where
1 siteUnited States
Study dates
22 Mar 2018to 3 Oct 2018
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 90 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Stroke participants:
  • age 30-90 years (stroke) or 18-50 years (able-bodied controls)
  • chronic stroke (>6 months post stroke)
  • ambulatory with or without the use of a cane or walker
  • able to walk for 2 minutes at the self-selected speed without an orthoses
  • resting heart rate 40-100 beats per minute
Show all 10Show fewer
  • Able-bodied participants:
  • age 18 to 50 years
  • no history of neurologic disease
  • no history of orthopedic disease or injury affecting the lower extremity.

Who cannot join

  • Stroke participants:
  • Cerebellar signs (ataxic ("drunken") gait or decreased coordination during rapid alternating hand or foot movements
  • History of lower extremity joint replacement
  • Inability to communicate with investigators
  • Neglect/hemianopia, or unexplained dizziness in last 6 months
  • Neurologic conditions other than stroke
Show all 12Show fewer
  • Orthopedic problems in the lower limbs or spine (or other medical conditions) that limit walking or cause pain during walking.
  • Able-bodied controls
  • History of neurologic disease
  • History of orthopedic disease or injury to the lower extremity in the past 6 months
  • Pain or discomfort during walking
  • Cardiovascular or medical condition affecting ability to exercise or walk.

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Emory Univeristy

    Atlanta, Georgia, 30322

Other trials in United States

About this study

Official title: Innovative Biofeedback Strategies for Gait Training

The long-term study goal is to develop a more engaging, motivating gait biofeedback methodologies specifically designed for post-stroke gait training. The current project aims to address fundamental questions regarding the optimal methodology to deliver AGRF biofeedback during gait, and the feasibility and preliminary efficacy of AGRF progression protocols for improved gait patterns and gait function. The study objectives are to (1) evaluate the immediate effects of biofeedback training methodology on gait biomechanics; and (2) evaluate the feasibility and short-term effects on gait performance of a real-time biofeedback protocol incorporating progression criteria (similar to those employed during clinical rehabilitative training).

Read the detailed description

Even after discharge from rehabilitation, residual gait deficits are prevalent in stroke survivors, leading to decreased walking speed and endurance. Because gait dysfunctions limit community mobility, stroke survivors and rehabilitation clinicians consider restoration of walking a major goal of rehabilitation. Biomechanical impairments, such as reduced knee and ankle flexion during swing phase negatively affect gait function and increase the risk for falls. During the stance phase, decreased contribution of the paretic leg to forward propulsion during paretic terminal stance is a critical post-stroke gait deficit shown to be correlated with hemiparetic severity, walking speed, and gait asymmetry. These gait deficits can lead to falls, increased energy cost of gait, and decreased endurance. Also, a slowed self-selected walking speed is one of the hallmarks of post-stroke gait, and greatly limits community participation in individuals post-stroke. Very few interventions provide targeted practice of biomechanically appropriate movement patterns exclusively or preferentially to the paretic leg. Biofeedback can enhance an individual's awareness of the impairment targeted during gait training, enabling self-correction of aberrant gait patterns. Real-time biofeedback gait training has been used for modulating step length asymmetry in people post-stroke. A recent study developed a protocol combining treadmill training with visual and auditory real-time biofeedback to increase anterior ground reaction force (AGRF). AGRF biofeedback may be a beneficial strategy to target unilateral propulsion deficits in people post-stroke. The goal of this study is to develop improved methodologies for AGRF gait biofeedback and to evaluate the feasibility and short-term effects of gait biofeedback. To achieve this goal, experiments will be performed on young able-bodied individuals as well as stroke survivors.

Being tested
biofeedback
Keywords
gait biofeedback, gait rehabilitation, paretic propulsion, gait motor learning
Medical subject headings
Myocardial Infarction, Gait Disorders, Neurologic

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • biofeedbackBehavioural

    treadmill walking with biofeedback regarding propulsion and other gait parameters

Study groups in NCT03466372
Study groupRoleWhat they receive
biofeedback 1Experimentalbiofeedback training with progression of targets
Receives: Behavioral: biofeedback
biofeedback 2Active comparatorbiofeedback training with progression of targets and speeds
Receives: Behavioral: biofeedback

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. paretic pushoff (AGRF)

    peak GRF generated by the leg affected by the stroke

    Measured: Immediately after the 6-minute biofeedback training bout (Post-0 minutes)

Secondary outcomes (2)
  1. non-paretic peak AGRF

    peak GRF generated by the leg not affected by the stroke

    Measured: Immediately after the 6-minute biofeedback training bout (Post-0 minutes)

  2. paretic trailing limb angle

    angle measuring limb orientation with respect to vertical at terminal stance

    Measured: Immediately after the 6-minute biofeedback training bout (Post-0 minutes)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted15 Mar 2018
  2. Study start22 Mar 2018
  3. Primary completion3 Oct 2018
  4. Study completion3 Oct 2018

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
20 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03466372
Sponsor's protocol ID
IRB00102559
Status last verified
May 2019
First submitted
1 Mar 2018
Last updated
14 May 2019
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Genthe K, Schenck C, Eicholtz S, Zajac-Cox L, Wolf S, Kesar TM. Effects of real-time gait biofeedback on paretic propulsion and gait biomechanics in individuals post-stroke. Top Stroke Rehabil. 2018 Apr;25(3):186-193. doi: 10.1080/10749357.2018.1436384. Epub 2018 Feb 19.

    PubMed 29457532
  • Schenck C, Kesar TM. Effects of unilateral real-time biofeedback on propulsive forces during gait. J Neuroeng Rehabil. 2017 Jun 6;14(1):52. doi: 10.1186/s12984-017-0252-z.

    PubMed 28583196
  • Santucci V, Alam Z, Liu J, Spencer J, Faust A, Cobb A, Konantz J, Eicholtz S, Wolf S, Kesar TM. Immediate improvements in post-stroke gait biomechanics are induced with both real-time limb position and propulsive force biofeedback. J Neuroeng Rehabil. 2023 Mar 31;20(1):37. doi: 10.1186/s12984-023-01154-3.

    PubMed 37004111

Questions about this trial

What is this clinical trial studying?

A study testing biofeedback in people with Stroke, Cardiovascular and Gait, Hemiplegic, run by Emory University at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 10 inclusion and 12 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 14 May 2019. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

paretic pushoff (AGRF) (time frame: Immediately after the 6-minute biofeedback training bout (Post-0 minutes)). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03466372, which also lists 3 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 14 May 2019.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in